BioNTech
IPOAdvancing science to transform cancer and infectious disease treatments
Mainz, Germany · Founded 2008 · $1.2B raised
- Headquarters
- Mainz
- Employees
- 5001–10000
- Founded
- 2008
- Business Model
- B2B
- Website
- biontech.com
- Total Funding
- $1.2B
- Last Round
- $325.0M Series BJul 2019
- Rounds
- 4
About
BioNTech is a global biotechnology company developing mRNA-based immunotherapies and vaccines for cancer and infectious diseases, leveraging immune engineering to translate science into survival.
Summary
BioNTech is a Biotech company based in Mainz, Germany, founded in 2008. It has raised $1.2B in total across 4 rounds, most recently a $325.0M Series B round in Jul 2019. Investors include Fidelity Management, MIG AG and European Investment Bank.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2020
Sign up to see all 6 rounds
Seed through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biontech"><img src="https://indexed.vc/api/badge/company/biontech" alt="BioNTech on Indexed.vc" width="260" height="76" /></a>